Jen-Kou Lin

5.1k total citations · 1 hit paper
102 papers, 3.8k citations indexed

About

Jen-Kou Lin is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Jen-Kou Lin has authored 102 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 40 papers in Surgery and 39 papers in Pathology and Forensic Medicine. Recurrent topics in Jen-Kou Lin's work include Colorectal Cancer Treatments and Studies (49 papers), Genetic factors in colorectal cancer (39 papers) and Colorectal Cancer Surgical Treatments (30 papers). Jen-Kou Lin is often cited by papers focused on Colorectal Cancer Treatments and Studies (49 papers), Genetic factors in colorectal cancer (39 papers) and Colorectal Cancer Surgical Treatments (30 papers). Jen-Kou Lin collaborates with scholars based in Taiwan, United States and China. Jen-Kou Lin's co-authors include Shung-Haur Yang, Shih‐Ching Chang, Wei-Shone Chen, Huann-Sheng Wang, Tzu-Chen Lin, Jeng‐Kai Jiang, Yuan‐Tzu Lan, Jeng‐Kae Jiang, Pei-Ching Lin and Chun‐Chi Lin and has published in prestigious journals such as PLoS ONE, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

Jen-Kou Lin

102 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial

2015 553 citations Jen-Kou Lin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jen-Kou Lin Taiwan	37	2.8k	1.1k	960	835	735	102	3.8k
Shung-Haur Yang Taiwan	33	2.2k 0.8×	873 0.8×	707 0.7×	755 0.9×	918 1.2×	127	3.3k
Ilhan Celik Germany	15	2.8k 1.0×	682 0.6×	1.6k 1.7×	911 1.1×	749 1.0×	31	3.9k
Tomohiro Nishina Japan	35	2.7k 1.0×	1.1k 1.0×	2.2k 2.3×	645 0.8×	665 0.9×	231	4.3k
Elizabeth Poplin United States	24	2.2k 0.8×	721 0.7×	1.2k 1.2×	452 0.5×	681 0.9×	80	3.2k
Yoshito Akagi Japan	32	1.8k 0.7×	966 0.9×	741 0.8×	457 0.5×	786 1.1×	272	3.3k
Carlo Barone Italy	31	2.3k 0.8×	671 0.6×	1.4k 1.4×	461 0.6×	769 1.0×	130	3.6k
Rainer Porschen Germany	33	2.0k 0.7×	1.2k 1.1×	1.1k 1.1×	878 1.1×	700 1.0×	114	3.2k
Aziz Zaanan France	33	2.2k 0.8×	1.0k 0.9×	1.2k 1.3×	1.4k 1.6×	564 0.8×	136	3.6k
Shingo Kameoka Japan	32	2.0k 0.7×	1.6k 1.4×	918 1.0×	421 0.5×	427 0.6×	176	3.4k
Angela Buonadonna Italy	30	2.8k 1.0×	826 0.8×	1.6k 1.7×	482 0.6×	936 1.3×	142	4.2k

Countries citing papers authored by Jen-Kou Lin

Since Specialization

Citations

This map shows the geographic impact of Jen-Kou Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jen-Kou Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jen-Kou Lin more than expected).

Fields of papers citing papers by Jen-Kou Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jen-Kou Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jen-Kou Lin. The network helps show where Jen-Kou Lin may publish in the future.

Co-authorship network of co-authors of Jen-Kou Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jen-Kou Lin. A scholar is included among the top collaborators of Jen-Kou Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jen-Kou Lin. Jen-Kou Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Hung‐Hsin, Chun‐Chi Lin, Yuan‐Tzu Lan, et al.. (2018). Differences in gene mutations according to gender among patients with colorectal cancer. World Journal of Surgical Oncology. 16(1). 128–128. 20 indexed citations

Lin, Pei-Ching, Hung‐Hsin Lin, Jen-Kou Lin, et al.. (2016). Mutation spectra of RAS gene family in colorectal cancer. The American Journal of Surgery. 212(3). 537–544.e3. 40 indexed citations

Lee, Yu‐Ting, Chia‐Jen Liu, Yu‐Wen Hu, et al.. (2015). Incidence of Second Primary Malignancies Following Colorectal Cancer. Medicine. 94(26). e1079–e1079. 27 indexed citations

Chen, Kuen‐Feng, Chueh‐Chuan Yen, Jen-Kou Lin, et al.. (2015). Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy. BMC Cancer. 15(1). 301–301. 17 indexed citations

Yang, Chih-Yung, Ren-Shyan Liu, Shung-Haur Yang, et al.. (2014). Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases. Clinical Cancer Research. 20(11). 2885–2897. 44 indexed citations

Wang, Hsei-Wei, Shung-Haur Yang, Jen-Kou Lin, et al.. (2014). Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism. Journal of Cancer Research and Clinical Oncology. 140(4). 561–571. 21 indexed citations

Lin, Jen-Kou, Pei-Ching Lin, Chien-Hsing Lin, et al.. (2014). Clinical Relevance of Alterations in Quantity and Quality of Plasma DNA in Colorectal Cancer Patients: Based on the Mutation Spectra Detected in Primary Tumors. Annals of Surgical Oncology. 21(S4). 680–686. 53 indexed citations

Chen, Hong‐Hwa, William Tzu-Liang Chen, Jen-Kou Lin, et al.. (2014). Health-related quality of life and cost comparison of adjuvant capecitabine versus 5-fluorouracil/leucovorin in stage III colorectal cancer patients. Quality of Life Research. 24(2). 473–484. 5 indexed citations

Weng, Shih‐Feng, et al.. (2013). Role for gender in colorectal cancer risk: a Taiwan population-based study. International Journal of Colorectal Disease. 28(7). 1001–1008. 13 indexed citations

10.

Lin, Jen-Kou, Chun‐Chi Lin, Huann-Sheng Wang, et al.. (2013). Neoadjuvant chemotherapy can improve outcome of colorectal cancer patients with unresectable metastasis. International Journal of Colorectal Disease. 28(10). 1359–1365. 16 indexed citations

11.

Lin, Jen-Kou, Wei-Shone Chen, Tzu-Chen Lin, et al.. (2011). A new classification scheme for recurrent or metastatic colon cancer after liver metastasectomy. Journal of the Chinese Medical Association. 74(11). 493–499. 9 indexed citations

12.

Liu, Chia‐Jen, Jen-Kou Lin, Wei-Shone Chen, et al.. (2011). Liver Abscess After Liver Metastasectomy is a Poor Prognostic Factor in Patients with Colorectal Cancer. Journal of Gastrointestinal Surgery. 15(10). 1798–1806. 3 indexed citations

13.

Chang, Shih‐Ching, Pei-Ching Lin, Shung-Haur Yang, et al.. (2009). Mitochondrial D-loop mutation is a common event in colorectal cancers with p53 mutations. International Journal of Colorectal Disease. 24(6). 623–628. 54 indexed citations

14.

Lin, Jen-Kou, et al.. (2008). Is C-Reactive Protein a Prognostic Factor of Colorectal Cancer?. Diseases of the Colon & Rectum. 51(4). 443–449. 41 indexed citations

15.

Lin, Jen-Kou, Shih‐Ching Chang, Huann-Sheng Wang, et al.. (2006). Distinctive clinicopathological features ofKi-ras mutated colorectal cancers. Journal of Surgical Oncology. 94(3). 234–241. 15 indexed citations

16.

Jiang, Jeng‐Kai, Shung-Haur Yang, & Jen-Kou Lin. (2005). Transabdominal Anastomosis After Low Anterior Resection: A Prospective, Randomized, Controlled Trial Comparing Long-Term Results Between Side-to-End Anastomosis and Colonic J-Pouch. Diseases of the Colon & Rectum. 48(11). 2100–2110. 48 indexed citations

17.

Chen, Chien-Chih, Rheun‐Chuan Lee, Jen-Kou Lin, Ling-Wei Wang, & Shung-Haur Yang. (2005). How Accurate is Magnetic Resonance Imaging in Restaging Rectal Cancer in Patients Receiving Preoperative Combined Chemoradiotherapy?. Diseases of the Colon & Rectum. 48(4). 722–728. 177 indexed citations

18.

Wang, Ling-Wei, Shung-Haur Yang, Jen-Kou Lin, et al.. (2005). Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer. Journal of Surgical Oncology. 89(4). 256–263. 17 indexed citations

19.

Chen, Wei-Shone, Liu H, Jacqueline Ming Liu, & Jen-Kou Lin. (2004). Sequence-dependent effect of a cyclooxygenase-2 inhibitor on topoisomerase I inhibitor and 5-fluorouracil-induced cytotoxicity of colon cancer cells. Anti-Cancer Drugs. 15(3). 287–294. 12 indexed citations

20.

Chen, Wei-Shone, et al.. (1992). Trend of large bowel tuberculosis and the relation with pulmonary tuberculosis. Diseases of the Colon & Rectum. 35(2). 189–192. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact